About the Ishihara laboratory
Our lab aims to develop highly translational immunotherapies.
We work in a team-based setting that facilitates immersion and discussion of issues in the clinic. Our state-of-the-art equipment allows for efficient data gathering and generation of novel drugs. Working in close collaboration with other laboratories fosters strong and multidisciplinary work.
Through our protein and cellular engineering approaches, we are working to make impactful discoveries that can be translated into the clinic to make improvements in human health.
Our research areas include cancer, regenerative medicine and autoimmune diseases.
We thank funders. Together, we will create novel therapeutics that are highly effective, minimum side-effects, and patient-friendly. Our lab is supported by Crowdfunding, MRC, Cancer Research UK, US department of defense, The Academy of Medical Sciences (acmedsci.ac.uk/), Pancreatic Cancer UK(pancreaticcancer.org.uk/), Prostate Cancer UK(prostatecanceruk.org/), Sarcoma UK(sarcoma.org.uk/), Rose tree trust, The Royal Society, and Pancreatic Cancer Research Fund (pcrf.org.uk/), The brain tumour charity (https://www.thebraintumourcharity.org/), the Institute for Cancer Vaccines and Immunotherapy (https://icvi.org.uk/), Little Princes Trust (https://www.littleprincesses.org.uk/)